RxDoctor Payments Data

Kalpit Shah, MD

Hand Surgery · Oceanside, CANPI 1326450040

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (50.3%), grants and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 34.9% of the total. 2025 is the largest year on record at $15,982, more than ten times the $751 reported in 2019. Among hand surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,529in general payments, 2019–2025

Across 154 payments — averaging $341.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$18K
  • Skeletal Dynamics Inc$16K
  • Impactortho, Inc.$6K
  • Endo Pharmaceuticals Inc.$6K
  • Acumed LLC$3K
  • Trimed, Inc.$576
  • plus $3K from 14 others

What the payments were for

  • Consulting fees$5,03710%
  • Speaking & faculty fees$2420%
  • Grants$10,00019%
  • Travel & lodging$4,2048%
  • Food & beverage$6,64713%
  • Education$26,40050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,529 in reported general payments places this provider in the 90th percentile of 249 hand surgery providers in California.

See all hand surgery providers in California

Medicare billing

Part B allowed, 2024
$421,576
Medicare patients
646
Services billed
6,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen108$635
Oxycodone Hcl54$163
Methylprednisolone18$95
Gabapentin12$49
Tramadol Hcl13$26

Paid to pharmacies, not to this prescriber.

Other hand surgery in Oceanside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →